Evonile Pharma Seeks Shareholder Approval via Postal Ballot

To approve the grant of employee stock options, equal to or more than 1% of the issued capital of the Company to the identified employee under Employee Stock Option Scheme 2026
Identified employee: Dr. Vikas Gupta, Managing Director and Chief Executive Officer of the Company
Requires separate shareholder approval under Regulation 6(3)(d) of SEBI (Share Based Employee Benefits and Sweat Equity) Regulations, 2021
Approval sought to authorize Board/Nomination and Remuneration Committee to grant Options in one or more tranches

To consider and approve the creation of charge on the assets of the Company under Section 180(1)(a) of Companies Act, 2013
For securing borrowings up to ₹1,500,00,00,000 (Rupees Fifteen Hundred Crores Only)
To secure borrowings availed/to be availed by the Company or any of its subsidiary company, associate company or any other group company
May include mortgage, hypothecation, pledge and/or charge on all or any assets of the Company

Remote e-voting period: Wednesday, October 14, 2026 at 9:00 AM (IST) to Thursday, November 12, 2026 at 5:00 PM (IST)
Cut-off date for determining voting rights: Friday, October 09, 2026
Results declaration: On or before Saturday, November 14, 2026
E-voting service provider: NSDL
Scrutinizer: Mr. S. N. Viswanathan, Practicing Company Secretary (FCS: 13685; COP No. 24335)
Alternate Scrutinizer: Ms. Ashwini Vartak (ACS 29463; COP No. 16723)

Dr. Vikas Gupta appointed as Managing Director and Chief Executive Officer effective July 29, 2026 for 5-year term
Brings over two decades of experience in commercial strategy, business transformation and brand building
Grant intended to align management incentives with shareholder value creation
Vesting and realization dependent on continued association and fulfilment of vesting conditions
Nomination and Remuneration Committee approved identification on October 08, 2026

Required for existing borrowings and future borrowing requirements
Needed to support business, operational and strategic requirements
Section 180(1)(a) of Companies Act, 2013 requires special resolution for creating security over whole/substantially whole undertaking

Notice sent electronically to members registered in Register of Members/List of Beneficial Owners as of cut-off date
Physical copies not sent pursuant to MCA Circulars
MUFG Intime India Private Limited appointed for email registration facilitation

All documents referred to in Notice available for inspection between 11:00 AM and 1:00 PM on working days
Members can send inspection requests to investor.relations@nilpharma.co.in

Resolutions, if passed, deemed passed on last date of e-voting: Thursday, November 12, 2026